ID.1
Item
diagnosed with type 2 diabetes for at least three months prior to study
boolean
C0011860 (UMLS CUI [1])
ID.2
Item
diabetes treated with metformin only
boolean
C0025598 (UMLS CUI [1])
ID.3
Item
give consent and sign an informed consent form.
boolean
C0021430 (UMLS CUI [1])
ID.4
Item
agree to follow specific requirements of birth control during participation.
boolean
C0700589 (UMLS CUI [1])
ID.5
Item
type i diabetes.
boolean
C0011854 (UMLS CUI [1])
ID.6
Item
treatment with insulin within 3 months prior to screening
boolean
C0745343 (UMLS CUI [1])
ID.7
Item
history of diabetic ketoacidosis or lactic acidosis
boolean
C0001125 (UMLS CUI [1,1])
C0011880 (UMLS CUI [1,2])
ID.8
Item
allergy or sensitivity to metformin or similar drugs or any medical conditions which prohibit metformin use
boolean
C0571648 (UMLS CUI [1])
ID.9
Item
excessive blood donation 56 days before the start of the study
boolean
C0005794 (UMLS CUI [1])
ID.10
Item
urinary tract or bladder infections within four weeks of study start
boolean
C0042029 (UMLS CUI [1,1])
C0600041 (UMLS CUI [1,2])
ID.11
Item
alcohol abuse or illicit drug use within 12 months of study start
boolean
C0085762 (UMLS CUI [1,1])
C0086190 (UMLS CUI [1,2])
ID.12
Item
receiving other investigational drugs or participating in other research trials within 30 of the study start
boolean
C0013230 (UMLS CUI [1])
ID.13
Item
use of prescription or non-prescription drugs, including vitamins, herbal and dietary supplements with 7-14 days of study start
boolean
C0033081 (UMLS CUI [1,1])
C0013231 (UMLS CUI [1,2])
ID.14
Item
live alone without regular, daily interactions with someone who can be an emergency contact
boolean
C0260794 (UMLS CUI [1,1])
C1552023 (UMLS CUI [1,2])